jadomycin-a and Breast-Neoplasms

jadomycin-a has been researched along with Breast-Neoplasms* in 2 studies

Reviews

1 review(s) available for jadomycin-a and Breast-Neoplasms

ArticleYear
Jadomycins: A potential chemotherapy for multi-drug resistant metastatic breast cancer.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:6

    Breast cancer causes the most cancer fatalities in women worldwide. Approximately one-third of breast cancers metastasize, or spread from primary tumors to other tissues, and have a 70% 5-year mortality rate. Current breast cancer treatments like doxorubicin and paclitaxel become ineffective when breast cancer cells develop multi-drug resistance and overexpress ATP-binding cassette transporters, as the transporters cause a substantial efflux of the chemotherapies. Jadomycins, a group of molecules isolated from Streptomyces venezuelae ISP5230, are shown to be cytotoxic against a variety of cancers, especially breast cancer. Furthermore, jadomycins retain their cytotoxic properties in multi-drug resistant breast cancer cells, as they are not expelled through ATP-binding cassette transporters. Here, we describe the research that supports the potential use of jadomycins as a novel chemotherapy in the treatment of multi-drug resistant, metastatic breast cancer. We present the supportive findings, as well as the mechanisms of action investigated thus far. These include copper-mediated reactive oxygen species generation, aurora B kinase inhibition, and topoisomerase IIα and IIβ inhibition. We also suggest future directions of jadomycin research, which will help to determine if jadomycins can be used as a breast cancer chemotherapy in clinical practice.

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Isoquinolines; Naphthoquinones; Streptomyces

2021

Other Studies

1 other study(ies) available for jadomycin-a and Breast-Neoplasms

ArticleYear
Stereochemical integrity of oxazolone ring-containing jadomycins.
    Chembiochem : a European journal of chemical biology, 2007, Jul-09, Volume: 8, Issue:10

    The jadomycins are a series of natural products produced by Streptomyces venzuelae ISP5230 in response to ethanol shock. A unique structural feature of these angucyclines is the oxazolone ring, the formation of which is catalyzed by condensation of a biosynthetic aldehyde intermediate and an amino acid. The feeding of enantiomeric forms of alpha-amino acids indicates that the amino acid is incorporated by S. venezuelae ISP5230 without isomerization at the alpha-carbon. The characterization of the first two six-membered E-ring-containing jadomycins is reported. These precursor-directed biosynthesis studies indicate flexibility in the acceptor substrate specificity of the glycosyltransferase, JadS. Analysis of cytotoxicity data against two human breast cancer cell lines indicates that the nature of the substitution at the alpha-carbon, rather than the stereochemistry, influences biological activity.

    Topics: Breast Neoplasms; Carbon; Catalysis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Ethanol; Humans; Isoleucine; Isoquinolines; Magnetic Resonance Spectroscopy; Naphthoquinones; Oxazolone; Stereoisomerism; Streptomyces

2007